Top compounds associated with response to CLDN5


Feature Type Standardized
Nominal ANOVA
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 8e-05
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.15 0.0003
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.11 0.0003
Download CSV